Novel mutation of the PTEN gene in an Italian Cowden's disease kindred

Stefania Scala, Paola Bruni, Lorenzo Lo Muzio, Michele Mignogna, Giuseppe Viglietto, Alfredo Fusco

Research output: Contribution to journalArticle

Abstract

Cowden disease (CD) is an autosomal dominant multiple hamartoma syndrome with an elevated risk of thyroid and breast cancers. The CD susceptibility gene has recently been identified as the PTEN/MMAC1/TEP1 gene localized at 10q23 and coding for a dual specificity protein phosphatase. We report the mutational analysis of the PTEN gene in one Italian CD kindred. By using the single strand conformation polymorphism technique and subsequent direct DNA sequencing of the polymerase chain reaction product, we identified a novel mutation in the exon 5 of the PTEN gene. A heterozygous germline TGT TAT transition was detected at the nucleotide 407; this causes the amino acid substitution cys136→tyr136 and the generation of a new NSI I restriction site. This mutation was not detected in the unaffected member of the family thereby indicating that it is causally linked to the disease. We ruled out that this mutation is a polymorphic variant because it was not detected in over 100 chromosomes analyzed. Using reverse trancriptase-polymerase chain reaction, we detected the expression of the mutant allele in lymphocytes and pathological tissues from an affected member of the family.

Original languageEnglish
Pages (from-to)665-668
Number of pages4
JournalInternational Journal of Oncology
Volume13
Issue number4
Publication statusPublished - Oct 1998

Keywords

  • Cowden's disease
  • PTEN gene

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Novel mutation of the PTEN gene in an Italian Cowden's disease kindred'. Together they form a unique fingerprint.

  • Cite this

    Scala, S., Bruni, P., Lo Muzio, L., Mignogna, M., Viglietto, G., & Fusco, A. (1998). Novel mutation of the PTEN gene in an Italian Cowden's disease kindred. International Journal of Oncology, 13(4), 665-668.